Back to Search Start Over

Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes

Authors :
Sylvain Cardinaud
Wilfried Posch
Klaus Loacker
Cornelia Lass-Flörl
Manfred P. Dierich
Annelies Mühlbacher
Adam J. Fletcher
Asier Sáez-Cirión
Chiraz Hamimi
Doris Wilflingseder
Gianfranco Pancino
Paul Eichberger
Arnaud Moris
Innsbruck Medical University = Medizinische Universität Innsbruck (IMU)
Immunité et Infection
Université Pierre et Marie Curie - Paris 6 (UPMC)-IFR113-Institut National de la Santé et de la Recherche Médicale (INSERM)
Régulation des Infections Rétrovirales
Institut Pasteur [Paris] (IP)
University College of London [London] (UCL)
This work was supported by the Austrian Science Fund [FWF, P22165 and P24598 to DW]and the Tyrolean Science Fund [TWF, project: D-155140-016-011 to WP]. The authors thankProf. Olivier Lambotte, Prof. Laurence Weiss, Dr. Caroline Lascoux, Dr. Olivier Taulera,Katia Bourdic, Jeannine Delgado, Maria Manea and all the other physicians and nurses whocared for the patients whose samples were included in the study. Additionally, we want tothank Polymun Scientific, Donaustrasse 99, Klosterneuburg, Austria who provided allreagents for p24 ELISA . The reagents ARP118 (HIV-BaL), ARP513 (HIVIg pool) andARP177.8 (HIV-92UG037) were obtained from the Centre for AIDS Reagents, NIBSCHPA UK, supported by the EC FP6/7 Europrise Network of Excellence, and NGIN consortiaand the Bill and Melinda Gates GHRC-CAVD Project and were donated by Dr.S.Gartner,Dr.M.Popovic, Dr.R.Gallo (Courtesy of the NIH AIDS Research and Reference ReagentProgram [BaL]), Dr B. Wahren, The Swedish Institute for Infectious Disease Control,Stockholm, Sweden [HIVIg pool] and the WHO UN AIDS Network for HIV-isolation andcharacterization [92UG037].
Innsbruck Medical University [Austria] (IMU)
Institut Pasteur [Paris]
Guibert, Marie-Genevieve
Source :
Journal of Allergy and Clinical Immunology, Journal of Allergy and Clinical Immunology, 2012, 130 (6), pp.1368--1374.e2. ⟨10.1016/j.jaci.2012.08.025⟩, Journal of Allergy and Clinical Immunology, Elsevier, 2012, 130 (6), pp.1368--1374.e2. ⟨10.1016/j.jaci.2012.08.025⟩
Publication Year :
2012
Publisher :
HAL CCSD, 2012.

Abstract

International audience; BACKGROUND: Control of HIV is suggested to depend on potent effector functions of the virus-specific CD8(+) T-cell response. Antigen opsonization can modulate the capture of antigen, its presentation, and the priming of specific CD8(+) T-cell responses. OBJECTIVE: We have previously shown that opsonization of retroviruses acts as an endogenous adjuvant for dendritic cell (DC)-mediated induction of specific cytotoxic T lymphocytes (CTLs). However, in some HIV-positive subjects, high levels of antibodies and low levels of complement fragments coat the HIV surface. METHODS: Therefore we analyzed the effect of IgG opsonization on the antigen-presenting capacity of DCs by using CD8(+) T-cell proliferation assays after repeated prime boosting, by measuring the antiviral activity against HIV-infected autologous CD4(+) T cells, and by determining IFN-γ secretion from HIV-specific CTL clones. RESULTS: We find that DCs exposed to IgG-opsonized HIV significantly decreased the HIV-specific CD8(+) T-cell response compared with the earlier described efficient CD8(+) T-cell activation induced by DCs loaded with complement-opsonized HIV. DCs exposed to HIV bearing high surface IgG levels after incubation in plasma from HIV-infected subjects acted as weak stimulators for HIV-specific CTL clones. In contrast, HIV opsonized with plasma from patients exhibiting high complement and low IgG deposition on the viral surface favored significantly higher activation of HIV-specific CD8(+) T-cell clones. CONCLUSION: Our ex vivo and in vitro observations provide the first evidence that IgG opsonization of HIV is associated with a decreased CTL-stimulatory capacity of DCs.

Details

Language :
English
ISSN :
00916749
Database :
OpenAIRE
Journal :
Journal of Allergy and Clinical Immunology, Journal of Allergy and Clinical Immunology, 2012, 130 (6), pp.1368--1374.e2. ⟨10.1016/j.jaci.2012.08.025⟩, Journal of Allergy and Clinical Immunology, Elsevier, 2012, 130 (6), pp.1368--1374.e2. ⟨10.1016/j.jaci.2012.08.025⟩
Accession number :
edsair.doi.dedup.....bf232d53dab4c2cefeed0fc77217a02a